Dr. Ing. h.c. F. Porsche AG (DRPRY) fair value: what the stock is really worth
As of Sep 25, 2026: fair value of Dr. Ing. h.c. F. Porsche AG $0.97, price $5.19, upside -81.3%, quality 38 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Structural break:
The valuation model sees a lasting decline in earnings power for this stock, the confidence band is broken. Treat the target with caution.
Weakest SetupStrongly overvalued and low quality.
!Fair value $0.9700 · Strongly overvalued (−81%)
!Quality 38/100
!Mixed Growth(revenue 5y +4.8 %/yr)
!Thin margins · 0.9% net margin (TTM)
✓Low debt · generates free cash flow
!Trails peers(3/15)
!Narrow moat23/100
!Evidence only low, so the estimate is less certain
Watch Dr. Ing. h.c. F. Porsche AG for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 23, 2026.
How to read this chart
47‑month range $4.10 – $11.77 · fair‑value band $0.7100 – $1.42 · the $5.19 price screens above the $0.9700 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 23, 2026.
Follow Dr. Ing. h.c. F. Porsche in your weekly email
Every Wednesday you see whether Dr. Ing. h.c. F. Porsche is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Dr. Ing. h.c. F. Porsche AG engages in automotive and financial services business in Germany, Europe, North America, China, and internationally. The company procures, develops, manufactures, and sells vehicles, as well as related services.
Show more
Dr. Ing. h.c. F. Porsche AG engages in automotive and financial services business in Germany, Europe, North America, China, and internationally. The company procures, develops, manufactures, and sells vehicles, as well as related services. It also offers leasing, dealer and customer financing, mobility services for Porsche brand vehicles, and other finance-related services. The company was formerly known as Porsche Fünfte Vermögensverwaltung AG and changed its name to Dr. Ing. h.c. F. Porsche AG in November 2009. The company was founded in 2009 and is headquartered in Stuttgart, Germany. Dr. Ing. h.c. F. Porsche AG is a subsidiary of Porsche Holding Stuttgart GmbH.
Stock analysis
Dr. Ing. h.c. F. Porsche AG (DRPRY) currently trades at $5.19, while our model-based Fair Value estimate is $0.9700, implying the stock looks roughly 435.0% overvalued today.
Show more
Valuation
Bull case: the Dividend Discount group reads highest at a median of $2.74 per share, and 2 of the 24 models we run sit above the $5.19 price.
Bear case: the Earnings-Based group reads lowest at $0.2900, and 22 of the 24 models stay below the price. Evidence for this calculation is low.
Scenario range: $0.7100 (bear) to $1.42 (bull), the price of $5.19 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 38/100 (below-average quality), in the Consumer Cyclical sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Dr. Ing. h.c. F. Porsche AG reported revenue of €36.3B in FY2025 versus €33.1B in FY2021, a compound +2.3%/yr. Reported net income was €431M in FY2025, compounding −42.8%/yr from FY2021.
Key figures
Market cap $47.3B · P/E ratio 103.8 · P/S ratio 1.23 · EPS (TTM) $0.0500 · Dividend yield 4.2% · Net margin 1.2% · Return on equity 0.8% · Return on assets (EBIT) 10.4%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 32 out of 100 (low confidence).
What moves the price
The share trades about 8% below its 52-week high and 27% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Consumer Cyclical peers we cover trades at 2% fair-value upside, at −81%, DRPRY screens richer than that median.
Fair Value models
The price assumes far more growth than our models allow for, so the models scatter widely ($0.2900 to $7.67). Read the Fair Value as a cautious anchor, not a price target; the Growth Forecast section shows what the price assumes.
Bear $0.7100Fair Value $0.9700Bull $1.42
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then ($0.0368 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.57/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−9.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−1.2%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.8%
Start year 2020 (pandemic)
Revenue growth 7 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.0%
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
−28.7%
Earnings growth per share plus dividend.
Earnings per share, growth per year−32.9%
Dividend (yield on the price)4.2%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.15% → 1%
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+37.1%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+0.8%
Yearly sales growth analysts expect, extended to five years.
After inflation (figures in EUR, euro area: IMF forecast 2.2% a year to 2030, 2.6% from 2016 to 2025) that is about +34.2% a year for the price and −1.3% for the forecasts.
Compare Dr. Ing. h.c. F. Porsche AG with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Auto Manufacturers · 116 stocks
Beats the industry median on 3/15 measures
Overall it trails its industry peers.
Valuation
Quality Score38 · Below median
Fair Value upside−81% · Bottom 25%
Profitability
Return on equity (TTM)1% · Below median
Return on assets1% · Below median
Net margin (TTM)1% · Below median
Operating margin (TTM)7% · Above median
Growth and dividend
Revenue growth−5% · Below median
Dividend yield (TTM)4.2% · Above median
Balance sheet
Debt / equity0.24× · Above median
Valuation Multiplesvs Auto Manufacturers median · lower = cheaper
P/E (TTM)103.8× · Priciest 25%
P/B2.17× · Pricier than median
P/S (TTM)1.40× · Priciest 25%
P/FCF108.8× · Priciest 25%
EV/EBITDA20.7× · Priciest 25%
PEG0.48× · Cheaper than median
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 47
FUTURE (revenue growth)0· sector 30
PAST (return on equity)3· sector 22
HEALTH (low debt)88· sector 93
DIVIDEND (yield)84· sector 54
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Dr. Ing. h.c. F. Porsche AG Fair Value". https://www.fairvalue-calculator.com/stock/DRPRY
Frequently asked questions
Is Dr. Ing. h.c. F. Porsche AG (DRPRY) overvalued or undervalued?
As of Sep 23, 2026, our model estimates a fair value of $0.9700 versus a price of $5.19, about −81% upside (overvalued).
What is the fair value of DRPRY?
Our model-based fair value for Dr. Ing. h.c. F. Porsche AG is $0.9700 (as of Sep 23, 2026), built from audited fundamentals. The current price: $5.19.
What is the quality score of DRPRY?
Dr. Ing. h.c. F. Porsche AG has a Quality Score of 38/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Dr. Ing. h.c. F. Porsche AG (DRPRY)?
Our model-based price target is the fair value of $0.9700 (as of Sep 23, 2026) from 24 valuation models. Cautious scenario $0.7100, optimistic scenario $1.42. It is a calculation from audited fundamentals, not an analyst target.
What is the Dr. Ing. h.c. F. Porsche AG stock forecast for 2026?
Our models put fair value at $0.9700, about −81% upside versus a price of $5.19 (overvalued). Cautious scenario $0.7100, optimistic scenario $1.42. The calculation is refreshed regularly with new filings.
What is the revenue of Dr. Ing. h.c. F. Porsche AG (DRPRY)?
Dr. Ing. h.c. F. Porsche AG reported trailing-twelve-month revenue of about €35.8B (latest available figure, as of Sep 23, 2026).
Does Dr. Ing. h.c. F. Porsche AG pay a dividend?
Dr. Ing. h.c. F. Porsche AG currently shows a dividend yield of about 4.20% relative to its recent price (as of Sep 23, 2026).
What growth is priced into Dr. Ing. h.c. F. Porsche AG (DRPRY)?
For today's price to be fair in a discounted-cash-flow model, Dr. Ing. h.c. F. Porsche AG would have to grow free cash flow by +37.1 % per year for five years (discount rate 8.9 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +4.8 % per year. As of Sep 23, 2026.
What discount rate (WACC) does the fair value of DRPRY use?
Our models discount Dr. Ing. h.c. F. Porsche AG at 8.9 %: a base by market capitalisation (large), damped by beta 0.87, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Dr. Ing. h.c. F. Porsche AG that is +37.1 % per year a year over ten years, using the same discount rate (8.9 %) and the same formula as our fair value.
How much growth has Dr. Ing. h.c. F. Porsche AG (DRPRY) delivered so far?
Over the past 5 years revenue at Dr. Ing. h.c. F. Porsche AG grew +4.8 % a year. The price currently implies +37.1 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Dr. Ing. h.c. F. Porsche AG (DRPRY) growing?
The median revenue growth in the sector is +2.5 % a year. That is the yardstick for the growth priced into Dr. Ing. h.c. F. Porsche AG (+37.1 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Dr. Ing. h.c. F. Porsche AG (DRPRY)?
The free-cash-flow yield on the price is 1.11 %: that much free cash flow Dr. Ing. h.c. F. Porsche AG produces per unit of market value. When it exceeds the discount rate of our models (8.9 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Dr. Ing. h.c. F. Porsche AG (DRPRY)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Dr. Ing. h.c. F. Porsche AG it is $0.9700 per share (as of Sep 23, 2026), against a price of $5.19. It is the blended result of 24 valuation models (cash flow, earnings, asset, dividend).
Is Dr. Ing. h.c. F. Porsche AG stock overvalued or undervalued in 2026?
As of Sep 23, 2026, DRPRY trades above its calculated fair value: price $5.19, fair value $0.9700, a gap of about −81% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of DRPRY?
No. The price is what the market pays today ($5.19); the fair value is what the company's own numbers justify ($0.9700). For Dr. Ing. h.c. F. Porsche AG the two are $4.22 per share apart. That gap is exactly why we show both numbers side by side.
How much is Dr. Ing. h.c. F. Porsche AG worth?
The market values Dr. Ing. h.c. F. Porsche AG at about $47.3B (market capitalisation, as of Sep 23, 2026). Per share that is $5.19; our models calculate a fair value of $0.9700 per share.
What do the bullish and bearish scenarios say about DRPRY?
Our models span a range for Dr. Ing. h.c. F. Porsche AG: cautious scenario $0.7100, base $0.9700, optimistic $1.42 per share (as of Sep 23, 2026, price $5.19). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of DRPRY?
Dr. Ing. h.c. F. Porsche AG trades at a price-to-earnings ratio of 103.8 (as of Sep 23, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $0.9700 is built from several models across several years. Other multiples: PEG 0.5, P/B 2.2, P/S 1.4, EV/EBITDA 20.7.
What is the PEG ratio of DRPRY?
The PEG ratio of Dr. Ing. h.c. F. Porsche AG is 0.48 (P/E divided by earnings growth, as of Sep 23, 2026). That is below 1, so growth is priced more cheaply than the earnings multiple alone suggests.
How solid is the balance sheet of Dr. Ing. h.c. F. Porsche AG (DRPRY)?
Balance-sheet figures for Dr. Ing. h.c. F. Porsche AG (as of Sep 23, 2026): return on equity 0.8%, debt of 0.24 per unit of equity. They feed the Quality Score of 38/100, which measures business quality independently of the share price.
How far is DRPRY from its 52-week high?
Dr. Ing. h.c. F. Porsche AG trades at $5.19, about 8% below its 52-week high of $5.65 and 27% above the low of $4.10 (as of Sep 25, 2026). Distance from the high says nothing about value: that is what the fair value of $0.9700 is for.
Which stocks are comparable to Dr. Ing. h.c. F. Porsche AG?
From the same area (Consumer Cyclical) we also value Tesla, Inc, Toyota Motor Corporation, BYD Company, General Motors Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Dr. Ing. h.c. F. Porsche AG stock attractive at the current price?
The data as of Sep 23, 2026: price $5.19, calculated fair value $0.9700 (−81%), Quality Score 38/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of DRPRY calculated?
We run Dr. Ing. h.c. F. Porsche AG through 24 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.9700, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.2 % above its aggregate fair value. Dr. Ing. h.c. F. Porsche AG itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Dr. Ing. h.c. F. Porsche AG (DRPRY)?
The closing price on Sep 25, 2026 was $5.19. Our model-based fair value is $0.9700, about −81% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Dr. Ing. h.c. F. Porsche AG right now?
The price sits above even our optimistic bull case ($1.42). The favourable scenario is already priced in. Weak quality (38/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range ($0.7100 to $1.42) leaves room in how you read the outcome.
Key figures of Dr. Ing. h.c. F. Porsche AG
How large is the market capitalisation of Dr. Ing. h.c. F. Porsche AG (DRPRY)?
The market capitalisation of Dr. Ing. h.c. F. Porsche AG is $47.3B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Dr. Ing. h.c. F. Porsche AG (DRPRY)?
The price-to-sales ratio of Dr. Ing. h.c. F. Porsche AG is 1.23 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Dr. Ing. h.c. F. Porsche AG (DRPRY)?
Earnings per share at Dr. Ing. h.c. F. Porsche AG are $0.0500 (price ÷ EPS = P/E 103.8). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Dr. Ing. h.c. F. Porsche AG (DRPRY)?
The dividend yield of Dr. Ing. h.c. F. Porsche AG is 4.2%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Dr. Ing. h.c. F. Porsche AG (DRPRY)?
The net margin of Dr. Ing. h.c. F. Porsche AG is 1.2% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Dr. Ing. h.c. F. Porsche AG (DRPRY)?
The return on equity (ROE) of Dr. Ing. h.c. F. Porsche AG is 0.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Dr. Ing. h.c. F. Porsche AG (DRPRY)?
On an EBIT basis the return on assets of Dr. Ing. h.c. F. Porsche AG is 10.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Dr. Ing. h.c. F. Porsche AG (DRPRY)?
The operating margin of Dr. Ing. h.c. F. Porsche AG is 7.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Dr. Ing. h.c. F. Porsche AG (DRPRY)?
Revenue at Dr. Ing. h.c. F. Porsche AG is growing −5.2% versus a year earlier (3y avg −1.2%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Dr. Ing. h.c. F. Porsche AG (DRPRY)?
Earnings per share at Dr. Ing. h.c. F. Porsche AG are growing −63.0% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Dr. Ing. h.c. F. Porsche AG (DRPRY) carry?
The net debt of Dr. Ing. h.c. F. Porsche AG is €6.4B (fiscal year 2025, ≈ 13.9 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Dr. Ing. h.c. F. Porsche AG in the live analysis
One click puts Dr. Ing. h.c. F. Porsche AG on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Thin data
Sep 23, 2026